Ana Boban, the incoming President of the European Association for Haemophilia and Allied Disorders (EAHAD) for 2026-2028, shared her vision for the future of bleeding disorder care in Europe. Her strategy focuses on advancing clinical practice, driving innovation in research, and crucially, supporting young clinicians and researchers.
Boban, a Consultant Haematologist at University Hospital Centre Zagreb, has been a key figure in European haemophilia clinical trials and guideline development. She emphasized the importance of addressing unmet needs in Europe and fostering long-term advancements beyond her presidency.